The lab has a focus on rare, genetic, neurodevelopmental and neurodegenerative disorders. We utilize patient-derived stem cell models to first study and characterize the disease and then screen novel therapeutic approaches. We work in collaboration with many departments to advance these treatments through animal models of the disease with a goal of initiating first in human clinical trials.
The Fink Lab
-
Our Research Goals
The Fink lab focuses on rare, genetic, neurodevelopmental and neurodegenerative disorders, utilizing patient-derived stem cell models to understand each disease and then screen novel therapeutic approaches.
-
Current Projects
- Diseases of Haploinsufficiency in the CNS
- CDKL5 Deficiency Disorder
- Jordan's Syndrome
- Huntington's Disease
- Angelman's Syndrome
- Rett Syndrom (X-linked disorder)
- CASK-Related Intellectual Disability
-
Our Team
- Katherine Lucot, Ph.D.
- David Cameron
- Jennifer Waldo, Ph.D.
- Isaac Villegas
- Casiana Gonzalez
- Paula Vij
- Klaudia Braczyk
- Yomira Palacios
- Mandeep Singh
- Victoria Du
- Ankita Singh
Clinical Trials
Learn about the different clinical trials we offer.
Giving
Join us to advance neurological health for all.
Fellowship Programs and Training Opportunities
Learn, grow and collaborate with our renowned researchers.